Send Inquiry

Request To Call Back

Natdac 60 Tablet

Get a Price/Quote

MOQ : 70 Packs

Natdac 60 Tablet Specification

Origin of Medicine
India

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
28 Tablets

Salt Composition
Daclatasvir (60mg)

Indication
Hepatitis C virus treatment (genotype 1, 2, 3, 4)

Drug Type
Allopathic

Physical Form
Tablets

Function
Anti-Bacterial

Recommended For
Chronic Hepatitis C virus infection

Dosage
As directed by physician

Dosage Guidelines
Take at the same time each day, do not skip doses

Suitable For
Adults

Quantity
28 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Side Effects
Fatigue, headache, nausea, anemia

Brand Name
Natdac 60

Intended Use
Used in combination with sofosbuvir for Hepatitis C treatment

Prescription Required
Yes

Classification
Direct-acting Antiviral

Marketed Form
Film coated tablet

Route of Administration
Oral

Strength
60 mg

Warnings and Precautions
Not to be used during pregnancy unless prescribed. Contraindicated in hypersensitivity to Daclatasvir. Consult doctor for liver or renal impairment.

Marketing Authorization Holder
Natco Pharma Ltd.

Therapeutic Class
Antiviral agents

Shelf Life
24 months

Natdac 60 Tablet Trade Information

Minimum Order Quantity
70 Packs

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Supply Ability
1500 Packs Per Week

Delivery Time
2 Days

Sample Available
No

Sample Policy
If order is confirmed we will reimburse the sample cost

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Natdac 60 Tablet

1.Technical Specifications

Medicine Type

Allopathic

Dose/Strength

60 mg

Packaging Size

28 Tablet

Packaging Type

Box

Manufactured By

Natco

Brand

Natdac

2. Product Description

Natdac Tablet contains Daclatasvir, a direct-acting antiviral agent targeting the HCV NS5A protein to inhibit viral replication. It is prescribed in combination with Sofosbuvir (with or without Ribavirin) for treatment of chronic hepatitis C infection, especially genotypes 1 and 3.

We are offering Daclatasvir Dihydrochloride Tablet that is utilized in combination with other medications to treat hepatitis C (HCV). The offered range is processed under the supervision of our experts. For strictly adhering to the international quality standards, this tablet is stringently tested by our quality inspectors upon different parameters. Daclatasvir Dihydrochloride Tablet can be used in combination include sofosbuvir, ribavirin, and interferon. The offered tablet is available at pocket friendly prices.

3. Therapeutic Uses

Treatment of chronic hepatitis C virus (HCV) infection
Used in combination with sofosbuvir ( ribavirin); NOT as monotherapy

4. Safety Profile & Side Effects

Common side effects:

Fatigue, headache, nausea, dizziness, insomnia, anemia, diarrhea

Precautions & serious risks:

Severe bradycardia and heart block when used with sofosbuvir, especially with drugs that reduce heart rate
Not recommended during pregnancy or breastfeeding; effective contraception required for both sexes for recommended duration
Caution in liver or kidney impairment, as well as in elderly or patients on interacting drugs (e.g. strong CYP3A inducers)
Not studied in patients under 18years; use not recommended
May cause dizziness or confusionadvise against driving or operating machinery if symptomatic

5. Usage Instructions & Dosage

Standard adult dosage: 60mg once daily, with or without food, at a fixed time every day
The complete treatment course (typically 1224 weeks) must be completed even if symptoms improve .
In case of missed dose, take as soon as remembered, but do not double up doses

Broad Hepatitis C Coverage

Natdac 60 Tablet targets multiple genotypes (1, 2, 3, and 4) of the Hepatitis C virus, making it versatile for managing chronic infections in adults. Its direct-acting antiviral mechanism works effectively in combination with sofosbuvir, contributing to improved treatment outcomes for patients diagnosed with Hepatitis C.

Safe and Reliable Treatment

This medicine is available only by prescription and requires careful monitoring by your healthcare provider. It is film-coated for ease of swallowing and designed to deliver a consistent dose of Daclatasvirvital for optimum antiviral activity. The tablets shelf life is 24 months, ensuring its efficacy when stored correctly.

FAQs of Natdac 60 Tablet:

Q: How should Natdac 60 Tablet be administered for Hepatitis C treatment?

A: Natdac 60 Tablet should be taken orally once daily, at the same time each day, as directed by your physician. It must always be used in combination with sofosbuvir for the effective management of chronic Hepatitis C infection.

Q: What are the key benefits of using Natdac 60 for Hepatitis C?

A: Natdac 60, combined with sofosbuvir, offers a potent antiviral effect against a broad range of Hepatitis C genotypes. It supports higher cure rates and improved liver health outcomes, especially in adults with chronic Hepatitis C.

Q: When should I take Natdac 60 Tablets during the day?

A: It is best to take Natdac 60 at the same time every day to maintain consistent drug levels in your body. Consult your doctor regarding the most suitable time based on your daily routine.

Q: Where should I store Natdac 60 Tablet to maintain its efficacy?

A: Store Natdac 60 Tablet below 30C, in a dry place protected from moisture and light. Proper storage helps preserve the tablets quality and extends its shelf life.

Q: What should I do if I miss a dose of Natdac 60?

A: If you miss a dose, take it as soon as you remember. However, if its almost time for your next dose, skip the missed dose and continue your regular schedule. Do not take a double dose to make up for a missed one.

Q: What are the possible side effects and precautions for Natdac 60 Tablet?

A: Common side effects may include fatigue, headache, nausea, and anemia. Do not use this medication during pregnancy unless advised by your doctor. It is contraindicated in individuals with hypersensitivity to Daclatasvir, and those with liver or renal impairment should consult a doctor before use.

Tell us about your requirement